The first diagnostic guidelines for NETs of the breast were published by Sapino et al. in 2001, which described tumors with over a 50% expression of neuroendocrine markers (synaptophysin and chromogranin) as primary neuroendocrine tumors of the breast [6]. The gene discussed is SYP; the disease is neuroendocrine neoplasm.